Navigation Links
Questcor Reports Solid Fourth Quarter Results
Date:3/1/2010

1, 2009.   The Company's financial performance in the fourth quarter of 2009 was driven primarily by:

  • a 223% increase in the number of new paid Acthar commercial prescriptions for the treatment of multiple sclerosis (MS) exacerbations versus the fourth quarter of 2008,
  • a sequential 56% increase in new paid Acthar commercial prescriptions for the treatment of infantile spasms (IS), and
  • lower sequential Medicaid usage.  

In addition to the financial improvement in the quarter, the Company also received an encouraging initial set of Acthar prescriptions for the treatment of nephrotic syndrome (NS). Also, during the fourth quarter, the FDA accepted for review Questcor's supplemental New Drug Application (sNDA) filing which seeks approval for an indication for Acthar in the treatment of IS.

Net sales totaled $25.9 million for the quarter ended December 31, 2009 compared to $13.9 million for the quarter ended September 30, 2009, and $27.0 million for the fourth quarter of 2008.  Net income for the f
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. APC Group, Inc. Reports Multi-Year Deal with Medical Device Manufacturer
2. CRF Health Reports Record Growth and Earnings
3. GeoVax Labs, Inc. Reports Fourth Quarter and Year End 2009 Financial Results
4. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
5. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
6. ERT Reports Fourth Quarter and Full Year 2009 Results
7. Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results
8. Transgenomic Reports Fourth Quarter Financial Results
9. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2009 Financial Results
10. Par Pharmaceutical Companies Reports Adjusted EPS of $0.65 for Fourth Quarter 2009
11. Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... LAWRENCEVILLE, N.J. , March 5, 2015 /PRNewswire/ ... today that the Company will host a conference ... provide an update on its development programs for ... and two newly acquired technology platforms, TheraPlas™ and ... a.m. ET on Thursday, March 12, 2015. To ...
(Date:3/5/2015)... and Markets ( http://www.researchandmarkets.com/research/4q7gwz/india_pharma ) has announced ... Accelerating growth to the next level - Moving up ... offering. Domestic sales improved in 2014, ... the market,s reaction to the new drug pricing policy. ... healthy, as the momentum continues and improving economic growth ...
(Date:3/5/2015)... HAMPTON, N.J. , March 5, 2015 /PRNewswire/ ... ), a leading global specialty biopharmaceutical company, and Ikaria, ... they have entered into a definitive agreement under which ... a Madison Dearborn -led investor group in a ... Subject to customary closing conditions, the parties expect the ...
Breaking Medicine Technology:Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12, 2015 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9
... 2, 2012  Trovagene, Inc. (Pink Sheets: TROV ... of a diagnostic test to determine the presence of ... specimens. The proprietary test (U.S. patent application pending) might, ... carrier status in males. The Company,s HPV ...
... Zogenix, Inc. (NASDAQ: ZGNX ), a pharmaceutical ... central nervous system disorders and pain, announced today that ... to the U.S. Food and Drug Administration (FDA) for ... candidate for the treatment of chronic pain.     ...
Cached Medicine Technology:Trovagene Announces Plans to Develop Proprietary Test for High Risk HPV Carrier Screening from Urine 2Trovagene Announces Plans to Develop Proprietary Test for High Risk HPV Carrier Screening from Urine 3Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 2Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 3Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 4Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 5Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 6
(Date:3/5/2015)... FL (PRWEB) March 05, 2015 Nutrition ... nutrition products, is pleased to offer reformulated Millennium 500 ... website, Millennium 500 is a German grade creatine supplement ... hydration, promote muscle recovery, and aid with overall strength ... compound that acts as a reserve energy source in ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Wimbledon ... which provides vascular, echocardiogram and NCV testing, ... as the Chief Medical Officer. Dr. Artel will be ... development of the WimbledonMED program and the continued growth ... passionate about working with Wimbledon Health Partners as a ...
(Date:3/5/2015)... Colorful packaging and marketing promises make it ... health. But all it really takes is reading the ... the March 2015 Harvard Health Letter . , ... director of the Department of Nutrition at Harvard-affiliated Brigham ... all the markers of good nutrition. , Whole grains ...
(Date:3/5/2015)... Obesity can cause the human body ... one drinks each day can help promote weight loss ... water advocate Sharon Kleyne and sports doctor Robert Weil, ... Powers of Water® radio show. , Weil is ... orthotics and sports medicine. His weekly radio show, ...
(Date:3/5/2015)... Developers and plugin specialists of Final ... transition pack entitled TranSlice Wipe for FCPX. , “TranSlice ... ease while maintaining a professional look,” Said Christina Austin, ... time saver with transitions our users will love.” , ... screen transitions with a new style. TranSlice Wipe allows ...
Breaking Medicine News(10 mins):Health News:Nutrition Leaders Offers Reformulated Millennium 500 German Grade Creatine 2Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 2Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 3Health News:Tips to Find the Healthiest Breakfast Cereals, From the March 2015 Harvard Health Letter 2Health News:Obesity is dehydrating and drinking water promotes weight loss say fresh water advocates 2Health News:Obesity is dehydrating and drinking water promotes weight loss say fresh water advocates 3Health News:Pixel Film Studios Released TranSlice Wipe Exclusively for Final Cut Pro X Editors 2
... plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the ... a 12-month study of DAYTRANATM (methylphenidate transdermal system), ... that DAYTRANA provided significant ADHD tolerability and symptom ... years. The study data was presented today ...
... Medically-complicated obesity is a societal problem that needs to ... is just one of the many complications of increased ... therefore there is an unmet need for pharmacologic treatment ... Journal of Gastroenterology by Dr. Baski-Bey et al. offers ...
... Calif., Oct. 26 Varian Medical,Systems, (NYSE: ... industry in overall,service performance by the ServiceTrak(TM) 2007 ... Ltd., a research company that,analyzes service trends in ... the basis of telephone interviews with,customers. Varian ...
... Highest Ranked Plan in Connecticut, FARMINGTON, Conn., Oct. ... plans by U.S. News & World Report/NCQA America,s Best,Health ... standards for,quality and customer satisfaction. ConnectiCare moved up one ... continues to be the highest ranked,plan in Connecticut. ...
... People with,diabetes who have asymptomatic heart disease may be ... hearts without surgical intervention, according,to a study being published ... on October 26, 2007., Researchers found that patients ... their cardiac risk factors with,medication were able to reverse ...
... Provide Funding and Support for "Patient Navigator,Program" Site ... Washington, EVERETT, Wash., Oct. 25 The ... Patient Navigator Program at,the Providence Regional Cancer Partnership ... part of a strategic nationwide effort to,significantly extend ...
Cached Medicine News:Health News:Long-term 12-month safety data on ADHD patch DAYTRANA 2Health News:Attenuation of NASH by stimulation of free fatty acid metabolism 2Health News:Varian Medical Systems Ranks First in Overall Service Performance in 2007 Survey of U.S. Radiation Oncology Professionals 2Health News:ConnectiCare Ranked #5 Best Health Plan in America 2Health News:Aggressively Treating Cardiac Risk Factors May Reverse Ischemia 2Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 2Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 3Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 4Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 5
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: